C4 Therapeutics, Inc. (CCCC)
NASDAQ: CCCC · Real-Time Price · USD
2.700
-0.080 (-2.88%)
At close: Feb 27, 2026, 4:00 PM EST
2.670
-0.030 (-1.11%)
After-hours: Feb 27, 2026, 7:52 PM EST
C4 Therapeutics Market Cap
C4 Therapeutics has a market cap or net worth of $261.67 million as of February 27, 2026. Its market cap has increased by 12.33% in one year.
Market Cap
261.67M
Enterprise Value
123.37M
1-Year Change
12.33%
Ranking
Category
Stock Price
$2.70
Market Cap Chart
Since the IPO on October 2, 2020, C4 Therapeutics's market cap has decreased from $772.72M to $261.67M, a decrease of -66.14%. That is a compound annual growth rate of -18.15%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ALX Oncology Holdings | 276.83M |
| Enlivex | 272.99M |
| Aardvark Therapeutics | 271.95M |
| Alector | 265.24M |
| Palisade Bio | 263.74M |
| Silence Therapeutics | 256.95M |
| Sol-Gel Technologies | 256.29M |
| Coherus Oncology | 249.62M |